CardioComm Solutions logo

CardioComm Solutions(OTC) EKGGF

Market Cap$1.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-97%
5 Year-63%
1 Year+150%
1 Month-8%
$0.01
+0.00%
+0.00Today
CardioComm Solutions last closing stock price
MetricPriceDate
Last closeUSD 0.012026-08-26
CardioComm Solutions stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.26%USD 0.012026-07-09
1 month-8.26%USD 0.012026-07-09
3 month+117.39%USD 0.002026-03-11
Year to date+36.99%USD 0.012025-11-06
1 year+150%USD 0.002025-08-14
3 year+51.52%USD 0.012023-07-28
5 year-62.83%USD 0.032021-08-23
Since inception-97.25%USD 0.362012-04-26

CardioComm Solutions Financials at a Glance

Market Cap

$1.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$280.31K

Net Income (TTM)

-CA$640.91K

EPS (TTM)

-$0.00

P/E Ratio

-5.26

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$0.01

Volume

60,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Nov 26, 2026

EKGGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CardioComm Solutions

CardioComm Solutions, Inc. is a Toronto-based company specializing in advanced technological solutions for cardiac monitoring. Established in 1989, the company offers a range of software and hardware products designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems.

Products and Services
  • Global ECG Management System (GEMS) for cardiac event monitoring
  • HeartCheck PEN and handheld ECG monitors for personal use
  • Application Service Provider (ASP) solutions for ECG management
Growth Outlook
  • Increasing demand for telemedicine solutions enhances market opportunities
  • Expansion into consumer-grade health products supports revenue growth
  • Proprietary technology positions the company for competitive advantage
Financial Highlights
  • Recent quarterly revenue of 90,135 CAD, showing potential for growth
  • Gross profit margin of 79% indicates strong product demand
  • Trailing twelve months (TTM) net income margin of -2.29% reflects ongoing investment in growth
CardioComm Solutions, Inc. operates in the healthcare information services sector, focusing on cardiac monitoring technologies. The company’s innovative products cater to both medical professionals and individual consumers, providing essential tools for effective cardiac care. The recent quarterly revenue indicates a stable demand for its offerings, while a high gross profit margin suggests that the products are well-received in the market. The growth outlook remains positive, driven by the increasing adoption of telemedicine and consumer health products. Despite current financial challenges, the proprietary technology and comprehensive service offerings position CardioComm for future success in the evolving healthcare landscape.
AI Generated • Oct 9, 2026

Industry

Health Care Technology

CEO

Etienne Anthony Grima

Headquarters

Toronto, ON M3C 3S2, CA

EKGGF Financials

Key Financial Metrics (TTM)

Gross Margin

76.87%

Operating Margin

-185.90%

Net Income Margin

-228.64%

Return on Equity

80.50%

Return on Capital

-31913.97%

Return on Assets

-326.65%

Earnings Yield

-19.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

197.58M

Volume

60.00K

Avg. Volume

1.23K

Financials (TTM)

Gross Profit

CA$215.47K

Operating Income

-CA$521.11K

EBITDA

-CA$504.85K

Operating Cash Flow

-CA$389.61K

Capital Expenditure

-CA$3.16K

Free Cash Flow

-CA$392.77K

Cash & ST Invst.

CA$38.35K

Total Debt

CA$922.50K

CardioComm Solutions Performance Analysis

CardioComm Solutions annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 764,92040.5%
20232023-12-31CAD 649,346-15.1%
20242024-12-31CAD 384,446-40.8%
20252025-12-31CAD 194,776-49.3%
CardioComm Solutions sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-38.8%
Q42025-12-3127.0%
Q12026-03-3161.1%
Q22026-06-30N/A
CardioComm Solutions annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD 0.00N/A
20232023-12-31CAD -0.00N/A
20242024-12-31CAD -0.0060.0%
20252025-12-31CAD -0.00137.5%
CardioComm Solutions sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-66.7%
Q42025-12-31N/A
Q12026-03-3130.0%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$90.14K

+25.1%

Gross Profit

CA$71.28K

+29.2%

Gross Margin

79.08%

N/A

Market Cap

$1.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$123.49K

N/A

Employees

16

N/A

Net Income

-CA$137.29K

-10.5%

EBITDA

-CA$98.95K

+21.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$38.35K

-19.2%

Total Debt

CA$922.50K

+69.6%

Accounts Receivable

CA$90.71K

+44.7%

Inventory

CA$12.57K

-53.4%

Long Term Debt

CA$383.43K

+2743.8%

Short Term Debt

CA$539.08K

+1.6%

Return on Assets

-3.27%

N/A

Return on Invested Capital

89.76%

N/A

Free Cash Flow

-CA$107.00K

+40.2%

Operating Cash Flow

-CA$106.68K

+40.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SMASSomatic Systems, Inc.
$0.00+0.00%
MDGPMedgroup Inc.
$0.00+0.00%
CNNACann American Corp.
$0.00-69.39%
MITIMitesco, Inc.
$0.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.79+10.24%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$142.52-10.31%
TQQQProShares Trust - ProShares UltraPro Qqq
$80.23-4.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$33.37+4.05%

Questions About EKGGF

What is the current price of CardioComm Solutions?

CardioComm Solutions is trading at $0.01 per share.

What is the 52-week range for CardioComm Solutions?

Over the past 52 weeks, CardioComm Solutions has traded between $0.00 and $0.01.

How much debt does CardioComm Solutions have?

As of the most recent reporting period, CardioComm Solutions reported total debt of CA$504.26K.

How much cash does CardioComm Solutions have on hand?

CardioComm Solutions reported CA$34.32K in cash and cash equivalents in its most recent financial results.

What is CardioComm Solutions’s dividend yield?

CardioComm Solutions does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.